心房颤动患者接受非维生素K拮抗剂口服抗凝药（NOAC）治疗时发生缺血性卒中：建议的治疗策略。 - Suppr

Suppr

超能文献

Ischemic stroke while on NOAC therapy in patients with atrial fibrillation: suggested treatment strategies.

作者信息

De Magistris Ilaria Leone, Paciaroni Maurizio

机构信息

Ilaria Leone De Magistris, Azienda Ospedaliera Di Perugia, Perugia, Italy.

出版信息

Intern Emerg Med. 2023 Jun;18(4):963-967. doi: 10.1007/s11739-023-03266-z. Epub 2023 May 3.

DOI:10.1007/s11739-023-03266-z

PMID:37133729

Abstract

摘要

相似文献

Ischemic stroke while on NOAC therapy in patients with atrial fibrillation: suggested treatment strategies.

Intern Emerg Med. 2023 Jun;18(4):963-967. doi: 10.1007/s11739-023-03266-z. Epub 2023 May 3.

Recurrent Ischemic Stroke and Cardiovascular Outcomes in Patients With Atrial Fibrillation With Ischemic Stroke Despite Direct Oral Anticoagulants.

Stroke. 2023 Apr;54(4):e145-e146. doi: 10.1161/STROKEAHA.122.041197. Epub 2023 Feb 28.

Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage.

Stroke. 2020 Feb;51(2):416-423. doi: 10.1161/STROKEAHA.119.028030. Epub 2019 Dec 9.

Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding.

Stroke. 2021 Jan;52(2):511-520. doi: 10.1161/STROKEAHA.120.030761. Epub 2021 Jan 8.

Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.

Int J Stroke. 2016 Jul;11(5):565-74. doi: 10.1177/1747493016632239. Epub 2016 Feb 29.

Novel Oral Anticoagulants for Primary Stroke Prevention in Hypertrophic Cardiomyopathy Patients With Atrial Fibrillation.

Stroke. 2019 Sep;50(9):2582-2586. doi: 10.1161/STROKEAHA.119.026048. Epub 2019 Jul 25.

[When does it seem appropriate to start a direct oral anticoagulant after an ischemic stroke associated with atrial fibrillation? The ELAN study].

G Ital Cardiol (Rome). 2024 Jan;25(1):3-5. doi: 10.1714/4165.41584.

What Is the Best Anticoagulant Therapy in Acute-Phase Ischemic Stroke With Nonvalvular Atrial Fibrillation?

Circ J. 2022 May 25;86(6):964-965. doi: 10.1253/circj.CJ-21-1002. Epub 2021 Dec 25.

Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea.

Adv Ther. 2022 Jul;39(7):3112-3130. doi: 10.1007/s12325-022-02151-z. Epub 2022 May 7.

Preceding direct oral anticoagulant administration reduces the severity of stroke in patients with atrial fibrillation - K-PLUS registry.

J Clin Neurosci. 2021 Jul;89:106-112. doi: 10.1016/j.jocn.2021.04.027. Epub 2021 May 6.

引用本文的文献

Acute Ischaemic Stroke in Patients Treated with Direct Oral Anticoagulants: Potential Causes, Clinical Characteristics, and Short-Term Outcomes.

Stroke Res Treat. 2024 Feb 10;2024:2285722. doi: 10.1155/2024/2285722. eCollection 2024.

Ischaemic stroke in a patient with non-valvular atrial fibrillation (NVAF) despite non-vitamin K oral anticoagulant (NOAC) therapy.

BMJ Case Rep. 2024 Jan 10;17(1):e258761. doi: 10.1136/bcr-2023-258761.

本文引用的文献

Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study.

Stroke. 2022 Aug;53(8):2620-2627. doi: 10.1161/STROKEAHA.121.038239. Epub 2022 May 11.

Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation.

J Neurol Neurosurg Psychiatry. 2022 Jun;93(6):588-598. doi: 10.1136/jnnp-2021-328391. Epub 2022 Apr 8.

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.

Lancet. 2022 Apr 9;399(10333):1383-1390. doi: 10.1016/S0140-6736(22)00456-1. Epub 2022 Apr 3.

Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis.

Europace. 2022 Jul 15;24(6):887-898. doi: 10.1093/europace/euab303.

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation.

Ann Med. 2021 Dec;53(1):1613-1620. doi: 10.1080/07853890.2021.1968031.

Ischaemic stroke in anticoagulated patients with atrial fibrillation.

J Neurol Neurosurg Psychiatry. 2021 Nov;92(11):1164-1172. doi: 10.1136/jnnp-2020-323963. Epub 2021 Aug 26.

Patients with Atrial Fibrillation receiving NOACs: The boundary between appropriate and inappropriate dose.

Eur J Intern Med. 2021 Jun;88:25-27. doi: 10.1016/j.ejim.2021.04.013. Epub 2021 May 8.

How lower doses of direct oral anticoagulants are interpreted in clinical practice: a national survey of the Italian Atherosclerosis, Thrombosis and Vascular Biology (ATVB) Study Group.

J Cardiovasc Med (Hagerstown). 2021 Dec 1;22(11):924-928. doi: 10.2459/JCM.0000000000001204.

Ischaemic stroke on anticoagulation therapy and early recurrence in acute cardioembolic stroke: the IAC study.

J Neurol Neurosurg Psychiatry. 2021 Oct;92(10):1062-1067. doi: 10.1136/jnnp-2021-326166. Epub 2021 Apr 26.

2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation.

Europace. 2021 Oct 9;23(10):1612-1676. doi: 10.1093/europace/euab065.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验